Elevated levels of myeloperoxidase, white blood cell count and 3-chlorotyrosine in Taiwanese patients with acute myocardial infarction

Clinical Biochemistry

Volumn 41, Issue 7-8, 2008, Pages 554-560

  Cheng, Mei Ling ^a,b   Chen, Chin Ming ^c   Gu, Po Wen ^a,b   Ho, Hung Yao ^a   Chiu, Daniel Tsun Yee ^a,b  

^a Graduate Institute of Medical Biotechnology   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

3 chlorotyrosine; Acute myocardial infarction; Myeloperoxidase

Indexed keywords

3 CHLOROTYROSINE; MYELOPEROXIDASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; ROC CURVE; SENSITIVITY AND SPECIFICITY; TAIWAN;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEROXIDASE; SENSITIVITY AND SPECIFICITY; TAIWAN; TYROSINE;

EID: 41849138905     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.02.006     Document Type: Article

References (40)

1. Health and National Health Insurance Annual Statistics Information Service, Cause of death statistics (2006), Department of Health of the Executive Yuan, Taiwan
2. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
3. Festa A., and Haffner S.M. Inflammation and cardiovascular disease in patients with diabetes: lessons from the diabetes control and complications trial. Circulation 111 (2005) 2414-2415
4. Zimmermann J., Herrlinger S., Pruy A., Metzger T., and Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55 (1999) 648-658
5. Rutgers A., Heeringa P., and Tervaert J.W. The role of myeloperoxidase in the pathogenesis of systemic vasculitis. Clin Exp Rheumatol 21 (2003) 55-63
6. Chisolm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 28 (2000) 1815-1826
7. Podrez E.A., Abu-Soud H.M., and Hazen S.L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med 28 (2000) 1717-1725
8. Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 (2002) 2894-2900
9. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44 (2004) 1945-1956
10. Gaut J.P., Yeh G.C., Tran H.D., et al. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A 98 (2001) 11961-11966
11. Rosen H., Crowley J.R., and Heinecke J.W. Human neutrophils use the myeloperoxidase-hydrogen peroxide-chloride system to chlorinate but not nitrate bacterial proteins during phagocytosis. J Biol Chem 277 (2002) 30463-30468
12. Sugiyama S., Okada Y., Sukhova G.K., Virmani R., Heinecke J.W., and Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158 (2001) 879-891
13. Lau D., and Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111 (2006) 16-26
14. Nicholls S.J., and Hazen S.L. The role of myeloperoxidase in the pathogenesis of coronary artery disease. Jpn J Infect Dis 57 (2004) S21-S22
15. Zhang R., Brennan M.L., Shen Z., et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277 (2002) 46116-46122
16. Bergt C., Pennathur S., Fu X., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 101 (2004) 13032-13037
17. Eiserich J.P., Baldus S., Brennan M.L., et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296 (2002) 2391-2394
18. Forgione M.A., Leopold J.A., and Losscalzo J. Roles of endothelial dysfunction in coronary artery disease. Curr Opin Cardiol 15 (2000) 409-415
19. Zidar N., Jeruc J., Balazic J., and Stajer D. Neutrophils in human myocardia infarction with rupture of the free wall. Cardiovasc Pathol 14 (2005) 247-250
20. Fu X., Kassim S.Y., Parks W.C., and Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276 (2001) 41279-41287
21. Sugiyama S., Kugiyama K., Aikawa M., Nakamura S., Ogawa H., and Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 1309-1314
22. Hazen S.L. Myeloperoxidase and plaque vulnerability. Arterioscler Thromb Vasc Biol 24 (2004) 1143-1146
23. Brennan M.L., Wu W., Fu X., et al. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem 277 (2002) 17415-17427
24. Kutter D., Devaquet P., Vanderstocken G., Paulus J.M., Marchal V., and Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit?. Acta Haematol 104 (2000) 10-15
25. Nikpoor B., Turecki G., Fournier C., Theroux P., and Rouleau G.A. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 142 (2001) 336-339
26. Domigan N.M., Charlton T.S., Duncan M.W., Winterbourn C.C., and Kettle A.J. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 270 (1995) 16542-16548
27. Mohiuddin I., Chai H., Lin P.H., Lumsden A.B., Yao Q., and Chen C. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res 133 (2006) 143-149
28. Denzler K.L., Borchers M.T., Crosby J.R., et al. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol 167 (2001) 1672-1682
29. Mita H., Higashi N., Taniguchi M., Higashi A., Kawagishi Y., and Akiyama K. Urinary 3-bromotyrosine and 3-chlorotyrosine concentrations in asthmatic patients: lack of increase in 3-bromotyrosine concentration in urine and plasma proteins in aspirin-induced asthma after intravenous aspirin challenge. Clin Exp Allergy 34 (2004) 931-938
30. Zhang C., Patel R., Eiserich J.P., et al. Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid. Am J Physiol Heart Circ Physiol 281 (2001) H1469-H1475
31. Vita J.A., Brennan M.L., Gokce N., et al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 110 (2004) 1134-1139
32. Malle E., Marsche G., Panzenboeck U., and Sattler W. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins. Arch Biochem Biophys 445 (2006) 245-255
33. Li L., Zhang Y., Chen Y.G., et al. Changes of neutrophil myeloperoxidase in coronary circulation among patients with acute coronary syndrome. Zhonghua Xin Xue Guan Bing Za Zhi 33 (2005) 1106-1108
34. Chiu C.A., Wu C.J., Yang C.H., et al. Levels and value of soluble P-selectin following acute myocardial infarction: evaluating the link between soluble P-selectin levels and recruitment of circulating white blood cells and the marker for the rapid diagnosis of chest pain. Chang Gung Med J 28 (2005) 699-707
35. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
36. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
37. Tsimikas S. Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease. Am J Cardiol 98 (2006) 9P-17P
38. Askari A.T., Brennan M.L., Zhou X., et al. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 197 (2003) 615-624
39. Horiuchi S., Sakamoto Y., and Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 25 (2003) 283-292
40. McCarthy J.J., Lehner T., Reeves C., et al. Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease. J Med Genet 40 (2003) 453-458